维普期刊资源整合服务平台（V6.5）

198篇 您的检索式：作者名="Halabi S"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer:Results of the cancer and leukemia group B 9182 study显示文摘	Kantoff PW Halabi S Conaway M	1999	J Clin Oncol1999，17，8：	1
2	Androgen receptor muta- tions in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663 显示文摘	Taplin ME Rajeshkumar B Halabi S	2003	Clin Oncol2003，21，：	1
3	Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer:results of the cancer and leukemia group B 9182 study显示文摘	Kantoff PW Halabi S Conaway M	1999	J Clin Oncol1999，17，：	1
4	Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients:a cancer and leukemia group B study显示文摘	Bok RA Halabi S Fei DT	2001	Cancer Res2001，61，6：	1
5	Phase Ⅱ study of high-dose fish oil capsules for patients with cancer-related cachexia显示文摘	Burns CP Halabi S Clamon G	2004	Can-cer2004，101，2：	1
6	Validation of a breast cancer risk assessment model in women with a positive family history显示文摘	Lustbsder ER halabi S	1994	J Natl Cancer nst1994，86，8：	1
7	Analgesic drug use and risk of ovarian cancer 显示文摘	Schildkraut JM Moorman PG Halabi S	2006	E pidemiology2006，17，1：	1
8	Serum lactatedehydrogenase predicts for overall survival benefit inpatients with metastatic renal cell carcinoma treatedwith inhibition of mammalian target of rapamycin显示文摘	Armstrong A J George D J Halabi S	2012	JClin OncoU2012，30，27：	1
9	Phase ffl trial of bevaci-zumab plus interferon alfa versus interferon alfa monotherapy in pa-tients with metastatic renal cell carcinoma : Final results of CALGB90206 显示文摘	Rini BI Halabi S’ Rosenberg JE	2010	J Clin Oncol2010，28，13：	1
10	Cancer and Leukemia Group B 90206:a randomized phase Ⅲ trial of interferon-alpha or interferon alpha plus anti-vascular endothelial growth factor antibody(bevacizumab) in metastatic renal cell carcinoma显示文摘	Halabi S Taylor J	2004	Clin Cancer Res2004，10，8：	1
11	A phase II trial of cisplatin ( C ) , gemcitabine ( G ) and gefitinib for ad- vanced urothelial tract carcinoma: results of cancer and 1 eukemia group B (CALGB) 90102 显示文摘	Philips G K Halabi S Sanford B L	2009	Ann Oncol2009，20，6：	1
12	Randomized controlled trial of early zoledronic acid in men with castration-sensitive prostate cancer and bone metastases: results of CALGB 90202(alliance) 显示文摘	Smith MR Halabi S Ryan CJ	2014	J Clin Oncol2014，32，11：	1
13	Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206 显示文摘	Rini BI Halabi S Rosenberg JE	2008	J Clin Oneol2008，26，33：	1
14	A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B pro- tocolg0008显示文摘	Stadler W M Halabi S Rini B	2006	Cancer2006，107，6：	1
15	A phase IItrial of temsirolimus in men with castration-resistantmeta-static prostate cancer显示文摘	Armstrong A J Shen T Halabi S	2013	Clin Genitourin Cancer2013，11，4：	1
16	Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone:Recommendations of the Prostate Cancer Clinical Trials Working Group显示文摘	SCHER HI HALABI S TANNOCK IF	2008	J Clin Oncol2008，26，：	1
17	The presence of human papillo-mavirus-16/-18E6, p53, and bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer显示文摘	Pillai MR Halabi S Mckalip A	1996	Cancer Epidemiol Biomarker Prey1996，5，5：	1
18	Phase III tri- al of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206 显示文摘	Rini BI Halabi S Rosenberg JE	2010	J Clin Oncol2010，28，13：	1
19	Antiandrogen withdrawal alone or in combination with ketoconazole in androgenindependent prostate cancer patients:a phase Ⅲ trial(CALGB9583)显示文摘	Small EJ Halabi S Dawson NA	2004	J Clin Oncol2004，22，6：	1
20	Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients 显示文摘	Bondy M Spitz M Halabi S	1993	Cancer Epidemiol Biomarkers Prey1993，2，2：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示